Spinal Anesthesia for Cesarean Delivery is Associated With Decreases in Regional Cerebral Oxygen Saturation as Assessed by Near- Infrared Spectroscopy
This study has been completed.
Sponsor:
University of Athens
Information provided by (Responsible Party):
Argyro Fassoulaki, University of Athens
ClinicalTrials.gov Identifier:
NCT01669135
First received: August 8, 2012
Last updated: August 17, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The cerebral oxygen saturation is assessed by means of near-infrared spectometry in parturients undergoing cesarean delivery under spinal anesthesia. The investigators hypothesis was that spinal anesthesia does not influence cerebral oxygen saturation.
| Condition | Intervention |
|---|---|
|
Cerebral Oxygen Saturation During Spinal Anesthesia for Cesarean Delivery |
Other: Spinal Anesthesia with cerebral oxygen saturation monitoring |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
Resource links provided by NLM:
Further study details as provided by University of Athens:
Primary Outcome Measures:
- cerebral oxygen saturation of the right frontal lobe [ Time Frame: Change from the performing of spinal anesthesia untill 1 minute after delivery ] [ Designated as safety issue: Yes ]Cerebral oxygen saturation is important as it may affect patient's outcome
Secondary Outcome Measures:
- cerebral oxygen saturation of the left frontal lobe [ Time Frame: 5, 10, 50 min after spinal,1 minute after delivery ] [ Designated as safety issue: Yes ]Cerebral oxygen saturation is important for patient's outcome
- Thigh oxygen saturation [ Time Frame: 5, 10, 50 min after spinal, 1 minute after delivery ] [ Designated as safety issue: Yes ]Thigh oxygen saturation may reflect blood redistribution due to spinal block
- Arterial Oxygenation [ Time Frame: 5, 10, 50 min after spinal, 1 minute after delivery ] [ Designated as safety issue: Yes ]Changes in arterial oxygenation may reflect blood redistribution due to spinal block
Other Outcome Measures:
- Hemodynamic changes (Changes in Blood Pressure (mmHg) and Heart rate (beats/min) [ Time Frame: 5, 10, 50 min after spinal, 1 minute after delivery ] [ Designated as safety issue: Yes ]Hemodynamic changes (changes in Blood Pressure and Heart rate) may reflect blood redistribution due to spinal block
| Enrollment: | 34 |
| Study Start Date: | December 2010 |
| Study Completion Date: | August 2012 |
| Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Spinal Anesthesia with cerebral oxygen saturation monitoring
The cerebral oxygen saturation of the right and left frontal lobe as well as the thigh oxygen saturation are monitored during spinal anesthesia by means of the near-infrared spectroscopy. Hemodynamic variables were recorded at the same time points.
|
Other: Spinal Anesthesia with cerebral oxygen saturation monitoring
Other Name: INVOS (cerebral oximeter model 5100, Somanetics, Troy, MI, USA)
|
Eligibility| Ages Eligible for Study: | 18 Years to 48 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Term healthy parturients
Exclusion Criteria:
- Body Mass Index > 35
- preeclampsia
- neurological,cardiovascular, respiratory disease
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Argyro Fassoulaki, MD, PhD, DEAA, University of Athens |
| ClinicalTrials.gov Identifier: | NCT01669135 History of Changes |
| Other Study ID Numbers: | M19-12-21-2010 |
| Study First Received: | August 8, 2012 |
| Last Updated: | August 17, 2012 |
| Health Authority: | Greece: Ethics Committee |
Keywords provided by University of Athens:
|
cerebral oximetry cesarean delivery |
Additional relevant MeSH terms:
|
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs |
Pharmacologic Actions Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 23, 2013